Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1988-9-15
|
pubmed:abstractText |
Innovative drug delivery systems have been developed for nifedipine and clonidine that prolong the pharmacologic activity of the medications, allowing once daily dosing. The nifedipine-GITS (gastrointestinal therapeutic system) tablet formulation and the clonidine-TTS (transcutaneous delivery system) patch may also reduce side effects in patients while preserving the therapeutic efficacy of the origin drug formulations (nifedipie capsule, clonidine tablet).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0733-8651
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
703-16
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:3331321-Administration, Cutaneous,
pubmed-meshheading:3331321-Angina Pectoris,
pubmed-meshheading:3331321-Clinical Trials as Topic,
pubmed-meshheading:3331321-Clonidine,
pubmed-meshheading:3331321-Delayed-Action Preparations,
pubmed-meshheading:3331321-Humans,
pubmed-meshheading:3331321-Hypertension,
pubmed-meshheading:3331321-Nifedipine
|
pubmed:year |
1987
|
pubmed:articleTitle |
Innovative drug delivery systems in cardiovascular medicine: nifedipine-GITS and clonidine-TTS.
|
pubmed:affiliation |
Albert Einstein College of Medicine, Bronx, New York.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Review
|